1. Clinical Overview
A fixed-dose combination of two methylxanthine derivatives, Etofylline and Theophylline, used primarily as a bronchodilator and respiratory stimulant. Etofylline is a theophylline derivative with improved solubility and a more favorable side effect profile. The combination provides synergistic bronchodilation, reduces bronchial hyperreactivity, and improves diaphragmatic contractility. It is a mainstay in the management of reversible airway obstruction in the Indian clinical setting.
| Onset | Duration | Bioavailability |
|---|---|---|
| Oral: 30-60 minutes; IV: Within 15 minutes. | Approximately 6-8 hours for immediate-release formulations. | Etofylline: ~80-90%; Theophylline: Highly variable (80-100% for immediate-release). |
2. Mechanism of Action
The primary mechanism is non-selective inhibition of phosphodiesterase (PDE) enzymes, particularly PDE3 and PDE4, leading to increased intracellular cyclic AMP (cAMP) and cyclic GMP (cGMP) in bronchial smooth muscle cells. This promotes smooth muscle relaxation (bronchodilation). Additional mechanisms include antagonism of adenosine receptors (A1 and A2), which inhibits adenosine-mediated bronchoconstriction and mast cell degranulation. It may also stimulate endogenous catecholamine release and inhibit prostaglandin-mediated inflammation.
3. Indications & Uses
- Bronchial Asthma (for relief of acute bronchospasm and prophylaxis)
- Chronic Obstructive Pulmonary Disease (COPD) including chronic bronchitis and emphysema
4. Dosage & Administration
Adult Dosage: One tablet (Etofylline 84.7mg + Theophylline 25.3mg) two to three times daily. Maximum: 3 tablets per day. Dosage must be individualized based on clinical response and serum level monitoring.
Administration: Take with a full glass of water, preferably after meals to minimize gastric irritation. Do not crush or chew sustained-release formulations (if applicable). Maintain consistent timing of doses. Avoid taking with high-fat meals which can increase absorption.
5. Side Effects
Common side effects may include:
- Nausea
- Vomiting
- Headache
- Insomnia
- Nervousness
- Restlessness
- Gastric discomfort/heartburn
- Increased diuresis
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Ciprofloxacin/Enoxacin | Markedly decreases Theophylline clearance, leading to toxicity (2-5 fold increase in levels). | Major |
| Phenytoin, Carbamazepine, Rifampicin | Increases Theophylline clearance, reducing efficacy. | Major |
| Cimetidine | Decreases Theophylline clearance, increases levels by 40-60%. | Major |
| Erythromycin, Clarithromycin | Decreases Theophylline clearance, moderate increase in levels. | Moderate |
| Beta-blockers (e.g., Propranolol) | Antagonize bronchodilator effect; may cause bronchospasm. | Moderate |
| Lithium | Theophylline increases renal lithium excretion, decreasing lithium levels. | Moderate |
| Warfarin | Theophylline may potentiate anticoagulant effect. | Moderate |
| Ketamine | May lower seizure threshold. | Moderate |
7. Patient Counselling
- Do take the medication exactly as prescribed, at the same times each day.
- Do not crush or chew tablets unless instructed.
- Do not take extra doses or double up if a dose is missed.
- Do inform all doctors and dentists about this medication.
- Do not start any new prescription, OTC, or herbal medicine without consulting your doctor.
- Do avoid excessive intake of caffeine-containing products (coffee, tea, cola, chocolate).
8. Toxicology & Storage
Overdose: Nausea, vomiting, hematemesis, tachycardia, cardiac arrhythmias (including ventricular tachycardia/fibrillation), hyperglycemia, hypokalemia, agitation, tremors, hyperreflexia, seizures (often the first sign of severe overdose in adults), metabolic acidosis, and death from cardiorespiratory arrest.
Storage: Store below 30°C, in a cool, dry place, protected from light and moisture. Keep out of reach of children. Do not use after the expiry date printed on the pack.